| Literature DB >> 25526867 |
Peter M Dracatos1, Mehar S Khatkar2, Davinder Singh3, Robert F Park4.
Abstract
BACKGROUND: Barley is an important cereal crop cultivated for malt and ruminant feed and in certain regions it is used for human consumption. It is vulnerable to numerous foliar diseases including barley leaf rust caused by the pathogen Puccinia hordei.Entities:
Mesh:
Year: 2014 PMID: 25526867 PMCID: PMC4302584 DOI: 10.1186/s12870-014-0382-4
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Seedling response of selected barley genotypes to five Australian pathotypes of Puccinia hordei
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| Sudan |
| ;1 N | ;1 N | 3+ | 3+ | ;1 N |
| Peruvian |
| ;12 = C | ;12 = CN | 3+ | 33+ | ;12 = CN |
| Estate |
| ; | ; | ; | ; | ; |
| Gold |
| ;12- | ;1 + N | ;12- | 3+ | 3+ |
| Magnif 104 |
| ;N | ;1 N | ;N | ;N | ;N |
| Bolivia |
| ;12 = C | ;12 = CN | 33 + C | 33+ | ;12 = CN |
| Cebada Capa |
| 0;N | 0;N | 0;N | 0;N | 0;N |
| Egypt 4 |
| 33+ | 33+ | 3+ | 3+ | 3+ |
| Abyssinian |
| ;12 = C | ;2 = C | ;12 = C | ;1-CN | 3+ |
| Clipper |
| 3+ | 3+ | 3+ | 3+ | 3+ |
| Clipper BC8 |
| 3+ | ;1CN | ;1 + N | 2++3 | 2++3 |
| Clipper BC67 |
| 12-N | 12+ | 22+ | 22-C | 2-C |
| Triumph |
| 12 = N | 12 = N | 22+ | 12 = N | 3+ |
| PI 531849 |
| ;N | ;-N | ;N | ;N | ;N |
| PI 584760 |
| ;12-C | ;12-C | 2+ | 2+ | 22 + C |
| Bowman*4/PI355447 |
| ;N | ;N | ;N | ;N | ;N |
| Q21861 |
| ;1 N | ;1 N | 3+ | 3+ | ;12 = N |
| 38P184 |
| ;-N | ;-N | ;-N | ;-N | ;-N |
| Reka 1 |
| ;N | ;1 + CN | ;12-N | ;1 N | ;12 = N |
| Prior |
| ;1 N | 3+ | ;1-N | ;N | 3+ |
| Ricardo |
| ;12-N | ;12-N | 2 + 2++ | 2++ | 12 = N |
| Cantala |
| 3+ | 3+ | 3+ | ;12 = CN | 3+ |
| Bandulla |
| 3+ | 3+ | 3+ | ;12 = CN | 3+ |
| Bussell |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Chebec |
| 12-C | 3+ | 12-CN | ;12 = CN | 3+ |
| Hannan |
| 3+ | 3+ | 3+ | ;12 = CN | 3+ |
| Lara |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Milby |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Moondyne |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Noyep |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Parwan |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Research |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Resibee |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
| Tilga |
| 3+ | 3+ | 3+ | ;12 = N, 3+ | 3+ |
| Stirling |
| 3+ | 3+ | 3+ | ;12 = N | 3+ |
1Plant Breeding Institute Cobbitty rust collection accession numbers.
2P- and P+ indicate avirulence and virulence, respectively, for Rph19.
3Culture kindly provided by Dr R.G. Rees, Queensland Department of Primary Industries.
4Original seed kindly supplied by Dr R.A. Pickering, New Zealand Institute for Crop and Food Research Limited.
Figure 1Seedling leaves of the infection types of (L to R): (1) CI9214 ( pathotype [pt] 253P-/Virulent ) (2) CI9214 (pt 210P+/avr ) (3) Stirling (pt 253P-/avr ) (4) Cantala (pt 253P-/avr ) (5) Cantala (pt 210P+/vir ) (6) Triumph (pt 253P-/avr ) (7) Gus (pt 253P-/vir) and (8) Gus (pt 210P+/vir).
Figure 2Partial linkage maps of linkage group seven of nine of the CI9214/Stirling doubled haploid population encompassing leaf rust resistance gene . Comparative map analysis was performed using common DArT markers between the CI9214/Stirling and the 'Bowman' consensus DArT-seq genetic map. DArT markers in common are in bold.
Figure 3Marker trait association analysis scans using Fisher’s exact test Vertical axis represents -log10 (P) values of the P-value of the marker trait association. The peaks above minimum threshold of 2 (P-value = 0.03) can be considered as significantly associated. The colours blue and red were used to differentiate between chromosomes (1H-7H). (A) Chromosome-wise plot and (B) genome-wide manhattan plot of chromosome 5HL derived from marker-trait association (MTA) analysis using Fisher’s exact test on 2 X 2 count table for seedling resistance to Puccinia hordei pathotype 253P- (binary scoring data) in the CI9214/Stirling doubled haploid population using 4, 500 DArT-seq markers. The –log10 of P-values were plotted against the positions on the physical Bowman genome assembly [20]. The peaks above minimum threshold of 2 (P-value = 0.03) can be considered as significantly associated.
Chi squared analysis of barley populations for tests for allelism with RphCantala
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
| Cantala/Triumph |
| F3 | 208 | No segregation# | <0.0001 | 267.429a | ||
| Cantala/PI531849 |
| F3 | 69 | 71 | 10 | 7:8:1 | 0.807 | 0.429a |
| Cantala/Estate |
| F3 | 112 | 87 | 18 | 7:8:1 | 0.012 | 8.779a |
| Cantala/Cebada Capa |
| F3 | 72 | 107 | 8 | 7:8:1 | 0.117 | 4.290a |
| Stirling/CI9214 |
| DH | 121 | 137 | 1:1 | 0.319 | 0.992b | |
Maximum recombination r = 1.1 cM (P = 0.01) and r = 0.7 cM (P = 0.05) calculated from Hanson [32] based on the hypothesis that the two loci are different.
#Chi squared values are denoted a and b for 2 and 1 degrees of freedom, respectively.
Figure 4Pedigree relationship of barley varieties ‘Stirling’ (PI 466919) and ‘Cantala’ (PI 483047/AUS 99074) (postulated to carry based on multipathotype tests and genetic mapping analysis) tracing the resistance back to Swedish and Czechoslovakian landraces LV-Gotland and LV-Kvasice-NA-Morave. ‘Cantala’ is derived from pedigrees ‘Kenia’ and ‘Erectoides 16’, a mutant derived from the Danish cultivar ‘Maja’.
Details of bioinformatic analyses of DArT-seq markers closely linked to RphCantala
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| DART4851 | 1 | 131.67 | 97.30 | 1.69E-17 | 5HL | 506583400 | 3.40E-27 | 506781405-506781469 | NB-ARC |
| DART4872 | 1 | NA | 90.74 | 1.69E-17 | 5HL | NA | 1.80E-11 | 509749584-509749620 | No match |
| DART7507 | 1 | NA | 97.30 | 5.33E-16 | 5HL | NA | 2.00E-16 | 506713993-506714061 | Tubulin -GTPase |
| DART7846 | 1 | NA | NA | 3.93E-12 | 5HL | NA | 1.30E-19 | 9520434-9520483 | Serine/threonine Protein Kinase |
| DART3079 | 0.937 | 130.9 | 102.04 | 1.38E-16 | 5HL | 506583400 | 5.80E-32 | 9519766-9519834 | Serine/threonine Protein Kinase |
| DART3263 | 0.937 | 134.72 | NA | 1.38E-16 | 5HL | 509518480 | 1.40E-29 | 509705303-509705371 | No match |
| DART5481 | 0.918 | 134.72 | 89.13 | 1.05E-12 | 5HL | 509518480 | 5.80E-32 | 506948877-506948945 | Inosine-5′-monophosphate dehydrogenase |
| DART2133 | 0.875 | 129.72 | 103.65 | 4.13E-15 | 5HL | 505380600 | 1.40E-29 | 505484624-505484692 | No match |
| DART2681 | 0.873 | 130.9 | 102.04 | 4.13E-15 | 5HL | 506583400 | 1.40E-29 | 506600697-506604765 | No match |
| DART6198 | 0.873 | 129.44 | 110.31 | 4.13E-15 | 5HL | 504740440 | 1.40E-29 | 504879962-504880030 | Cytochrome P450 |
| DART4228 | 0.867 | 129.72 | 103.64 | 1.52E-14 | 5HL | 505380600 | 5.80E-32 | 505484082-505484150 | No match |
| DART4182 | 0.867 | 129.83 | 110.307 | 5.60E-14 | 5HL | 505380600 | 5.80E-32 | 505506713-505506781 | AP2 transcription factor |
| DART5422 | 0.857 | 129.83 | 111.92 | 7.50E-13 | 5HL | 505380600 | 1.40E-29 | 505507578-505507646 | AP2 transcription factor |
| DART461 | 0.817 | 129.44 | 115.15 | 6.41E-14 | 5HL | 504780440 | 5.80E-32 | 504808312-504808380 | Uncharacterised protein |
NA, not available.
Summary information for significant DArT-seq markers in linkage disquilibrium (r2 > 0.8) with RphCantala on chromosome 5HL
|
|
|
|
|---|---|---|
|
| 100025017|F|0-28:G > C-28:G > C | TGCAGCAAAAATAGCACCGCCACACAACGTGCGCGGCAGCGCTCCCTCCAGCGACGCGACGCCTAGGAT |
|
| 100020485|F|0-40:G > A-40:G > A | TGCAGGGGGCAAGAGCAAACAAGGCATGATGAGCAAACCAGGCATGGTTGAGAGATCAGGCTAATTGTT |
|
| 100023795|F|0-13:G > A-13:G > A | TGCAGTACCTCGCGCTCTCCGGCAACGAGCTGTCTGGCAAGATACCGCCGAGATCGGAAGAGCGGTTCA |
|
| 100017949|F|0-37:A > G-37:A > G | TGCAGCTCGAAGAGACCCTTGGGAATGGAGCCGTTCAAGTAGTTCTCTCCGAGACGGATACGGCTCAAG |
|
| 100023711|F|0--33:C > A | TGCAGGCTCCCGCAGCCGCTGCTCCGTTCATCCCCCAGCAGCACCAGTACGTCACTCAGACGGGCACGG |
|
| 100009066|F|0--42:A > G | TGCAGCCAACCTTGGATGGAACACACAGAAAACCAGTATGCCAGTCCTCGATTTAAAGATGGGGCTAGA |
|
| 100025595|F|0--17:C > A | TGCAGTCCTGCTCATCTCTTCTTATGGTGACTACATGTTCTTCTTCATCTGGCTGGTCTGAGTTGGATG |
|
| 100009568|F|0--11:A > G | TGCAGTGGAATATAGCAAGGGCGGAGCAGCACAGTCAGTCAAGTCTGCATGCATGCGAGCAACCGTTGC |
|
| 100012213|F|0-56:T > C-56:T > C | TGCAGGTTTTTGAACTTTGAAGAACTCGCGCCGCTGCCTTGGGAAAATGTTTGAATTGTCCAAGGACAT |
|
| 100017110|F|0-68:A > G-68:A > G | TGCAGTTAGTCCAAGAAAGAGGAAAGCTGATGATGGTCTCAGTCTCAGTCCAAGAAAGAGGAAAGCTGA |
|
| 100011760|F|0-59:G > A-59:G > A | TGCAGATTTGTAGTCCACTAGGTACTAGTACTATCTTGTAGCGAGATTGCGAGGTTGCAGTCTCAGGGA |
|
| 100021856|F|0-28:C > A-28:C > A | TGCAGATGGAGACGAGGAGAAGCACGATCGATCCCAGGCCAAAAGGTCCAGCAAATGACATGCAAAGAG |
|
| 100004133|F|0-16:C > T-16:C > T | TGCAGAGCTCCTCAACCGTGCCTATTTATCTGCACATGGAGCCTTCAGGGCTTCAGGAAAAATCGCATC |
|
| 100021552|F|0--65:T > C | TGCAGGCATGATCGGAAGTTTTCCCATGCCGCCTCATTCACATCCCAACCGAAATCAACAACAAATAAG |
DArT locus names used throughout manuscript derived from clone ID/SNP variant and associated sequence read.
Bioinformatic analysis of functional annotation based on Pfam of the 75 predicted genes in the genomic region on Morex 5HL at the RphCantala locus based on linkage disequilibrium analysis performed on linked DArT-seq markers
|
|
|
|
|
|---|---|---|---|
| MLOC_67435 | Chromosome 5: 504,807,504-504,808,889 | Uncharacterised protein | 1282 |
| MLOC_63880 | Chromosome 5: 504,837,984-504,844,416 | Uncharacterised protein | 4770 |
| MLOC_63879 | Chromosome 5: 504,837,985-504,840,518 | Peptidase domain | 1900 |
| MLOC_14877 | Chromosome 5: 504,848,281-504,851,127 | Uncharacterised protein | 2578 |
| MLOC_72642 | Chromosome 5: 504,851,380-504,854,051 | Uncharacterised protein/transmembrane | 818 |
| MLOC_15752 | Chromosome 5: 504,856,869-504,860,258 | Uncharacterised protein//serine/threonine protein kinase | 1279 |
| MLOC_67813 | Chromosome 5: 504,866,847-504,868,082 | Uncharacterised protein | 156 |
| MLOC_58355 | Chromosome 5: 504,868,629-504,870,096 | Uncharacterised protein/Myb homeobox | 96 |
| MLOC_39379 | Chromosome 5: 504,881,559-504,882,690 | CytochromeP450/uncharacterised protein | 193 |
| MLOC_55782 | Chromosome 5: 505,224,634-505,228,648 | Uncharacterised protein/Bromodomain | 350 |
| MLOC_12507 | Chromosome 5: 505,231,551-505,235,061 | Transmembrane domain/uncharacterised protein | 99 |
| MLOC_56550 | Chromosome 5: 505,251,077-505,252,833 | Uncharacterised protein | 212 |
| MLOC_67579 | Chromosome 5: 505,267,327-505,268,018 | Uncharacterised protein | 73 |
| MLOC_79114 | Chromosome 5: 505,304,761-505,305,695 | Uncharacterised protein | 180 |
| MLOC_38843 | Chromosome 5: 505,401,971-505,402,516 | Uncharacterised protein/zipper | 144 |
| MLOC_22183 | Chromosome 5: 505,411,541-505,418,638 | Uncharacterised protein | 345 |
| MLOC_22184 | Chromosome 5: 505,411,592-505,420,058 | Microtubule-associated protein | 556 |
| MLOC_44070 | Chromosome 5: 505,421,803-505,425,401 | Uncharacterised protein | 346 |
| MLOC_61309 | Chromosome 5: 505,435,524-505,436,686 | Uncharacterised protein | 176 |
| MLOC_67384 | Chromosome 5: 505,437,805-505,442,456 | Uncharacterised protein/BIPPOZ fold | 190 |
| MLOC_14335 | Chromosome 5: 505,450,976-505,451,416 | Uncharacterised protein | 46 |
| MLOC_78241 | Chromosome 5: 505,457,197-505,458,593 | Glycosyltransferase 2 | 363 |
| MLOC_37117 | Chromosome 5: 505,487,438-505,491,448 | Uncharacterised protein/MIP1 Leuczipper | 608 |
| MLOC_63425 | Chromosome 5: 505,505,232-505,509,647 | Uncharacterised/AP2 transcription factor | 631 |
| MLOC_58589 | Chromosome 5: 505,517,232-505,521,660 | Eukaryotic translation initiation factor 3 subunit C | 868 |
| MLOC_71335 | Chromosome 5: 505,523,834-505,525,773 | Cytochrome P450/Uncharacterised protein | 453 |
| MLOC_44341 | Chromosome 5: 505,572,931-505,576,253 | Uncharacterised protein | 515 |
| MLOC_11008 | Chromosome 5: 505,604,769-505,610,921 | Kinesin motor domain/uncharacterised protein | 340 |
| MLOC_55124 | Chromosome 5: 506,586,998-506,588,618 | Ribosomal S14/predicted protein | 56 |
| MLOC_55125 | Chromosome 5: 506,594,987-506,597,286 | Uncharacterised protein | 284 |
| MLOC_64140 | Chromosome 5: 506,607,831-506,611,618 | Malate dehydrogenase | 358 |
| MLOC_39143.3 | Chromosome 5: 506,613,176-506,622,502 | Uncharacterised protein | 503 |
| MLOC_4524 | Chromosome 5: 506,631,764-506,637,466 | Uncharacterised protein | 144 |
| MLOC_63065 | Chromosome 5: 506,640,602-506,644,654 | Uncharacterised protein/protein-kinase domain leucine rich repeat | 608 |
| MLOC_37278 | Chromosome 5: 506,647,621-506,649,939 | Uncharacterised/cytP450 | 515 |
| MLOC_11920 | Chromosome 5: 506,671,388-506,671,569 | Uncharacterised protein | |
| MLOC_61101 | Chromosome 5: 506,676,442-506,678,678 | Alpha/beta hydrolase domain/uncgharacterised | 377 |
| MLOC_52788 | Chromosome 5: 506,712,820-506,716,335 | Alpha-tubulin 4 | 451 |
| MLOC_52896.1 | Chromosome 5: 506,720,817-506,722,983 | Myb/Homeobox/Uncharacterised protein | 299 |
| MLOC_77955 | Chromosome 5: 506,728,560-506,729,777 | Homeobox/leucine zipper/uncharacterised protein | 154 |
| MLOC_52360.1 | Chromosome 5: 506,734,900-506,736,938 | tRNA-butesine synthase/uncharacterised protein | 240 |
| MLOC_52361 | Chromosome 5: 506,737,533-506,741,133 | Pentatricopeptide/uncharacterised | 682 |
| MLOC_17956 | Chromosome 5: 506,743,784-506,750,717 | Uncharacterised protein/N-acetylglucosaminyl transferase component (Gpi1) | 541 |
| MLOC_66827 | Chromosome 5: 506,758,816-506,764,116 | AMP-binding enzyme/uncharacterised protein | 700 |
| MLOC_71512 | Chromosome 5: 506,765,725-506,767,027 | Oligopeptide transporter | 292 |
| MLOC_71514 | Chromosome 5: 506,771,066-506,774,511 | Uncharacterised protein | 947 |
| MLOC_36533 | Chromosome 5: 506,774,624-506,778,739 | Giberellin signalling | 548 |
| MLOC_36533 | Chromosome 5: 506,779,918-506,782,319 | NB-ARC protein/uncharacterised protein | 591 |
| MLOC_79498 | Chromosome 5: 506,783,900-506,786,958 | Peptidase/protein inhibition/Uncharacterised protein | 377 |
| MLOC_17927 | Chromosome 5: 506,792,732-506,798,457 | WRKY transcription factor /Uncharacterised protein | 1032 |
| MLOC_66348 | Chromosome 5: 506,818,362-506,820,563 | NAM protein | 337 |
| MLOC_16892 | Chromosome 5: 506,827,938-506,828,895 | Tetraspanin/peripherin/uncharacterised protein | 183 |
| MLOC_14114 | Chromosome 5: 506,834,758-506,838,333 | FAD reductase/uncharacterised | 430 |
| MLOC_23699 | Chromosome 5: 506,884,357-506,888,420 | RNA polymerase III | 120 |
| MLOC_70664 | Chromosome 5: 506,907,468-506,911,192 | Lipoxygenase | 863 |
| MLOC_17894 | Chromosome 5: 506,912,481-506,913,432 | Uncharacterised protein | 145 |
| MLOC_10360 | Chromosome 5: 506,913,595-506,916,553 | NBS-ARC-LRR disease resistance protein/Uncharacterised | 766 |
| MLOC_19228 | Chromosome 5: 506,923,278-506,929,445 | Cullin repeat-like superfamily | 351 |
| MLOC_3679 | Chromosome 5: 506,929,610-506,930,486 | GTP binding Elongation factor | 113 |
| MLOC_10567 | Chromosome 5: 506,948,227-506,953,875 | Inosine-5′-monophosphate dehydrogenase | 496 |
| MLOC_44818 | Chromosome 5: 506,995,429-506,995,800 | Uncharacterised protein | 30 |
| MLOC_76586 | Chromosome 5: 506,996,531-506,997,720 | Uncharacterised protein | 51 |
| MLOC_66071 | Chromosome 5: 509,522,514-509,527,272 | Calmodulin binding protein/uncharacterised | 588 |
| MLOC_66074 | Chromosome 5: 509,528,020-509,529,376 | Photosystem I reaction center subunit III | 439 |
| MLOC_62114 | Chromosome 5: 509,534,583-509,540,642 | Calmodulin binding protein/uncharacterised | 615 |
| MLOC_61300 | Chromosome 5: 509,556,146-509,556,624 | Uncharacterised protein/Zinc finger | 137 |
| MLOC_61302 | Chromosome 5: 509,560,844-509,561,551 | Uncharacterised protein/Zinc finger | 156 |
| MLOC_2917 | Chromosome 5: 509,561,748-509,564,141 | Protein binding GTP-Elongation Factor | 322 |
| MLOC_66343 | Chromosome 5: 509,613,233-509,613,914 | Uncharacterised protein | 59 |
| MLOC_7003 | Chromosome 5: 509,663,223-509,664,904 | Chaperone J | 96 |
| MLOC_4695 | Chromosome 5: 509,722,893-509,727,266 | F-box domain cyclin/Uncharacterised protein | 411 |
| MLOC_66212 | Chromosome 5: 509,843,699-509,844,569 | Uncharacterised protein | 245 |
| MLOC_4789 | Chromosome 5: 509,860,275-509,861,218 | Uncharacterised protein | 146 |
| MLOC_12556 | Chromosome 5: 509,866,159-509,866,865 | Uncharacterised protein | 110 |
| MLOC_66971 | Chromosome 5: 509,878,445-509,880,991 | Ribose 5P isomerase |